In summary, we characterized the progressive impairment of islet vascular function and its metabolic consequences in a WD-induced obese mouse model and identified intra-islet VEGF-A/VEGFR2 signaling obstruction as a key underlying mechanism. This evidence concerns the gene VEGFA and Wilson disease.